Warning: include_once(/home/vhio.net/tmp/config.tmp.QkEIZL): Failed to open stream: No such file or directory in /usr/home/vhio.net/web/wp-content/themes/thegem/inc/template-tags.php on line 2 Warning: include_once(): Failed opening '/home/vhio.net/tmp/config.tmp.QkEIZL' for inclusion (include_path='.:') in /usr/home/vhio.net/web/wp-content/themes/thegem/inc/template-tags.php on line 2 Warning: Constant WP_AUTO_UPDATE_CORE already defined in /usr/home/vhio.net/web/wp-config.php on line 126 Warning: Constant CORE_UPGRADE_SKIP_NEW_BUNDLED already defined in /usr/home/vhio.net/web/wp-config.php on line 129 Warning: Constant DISALLOW_FILE_EDIT already defined in /usr/home/vhio.net/web/wp-config.php on line 132 REGISTRATION & ABSTRACT SUBMISSION NOW OPEN: VHIO´s Special Symposium on Towards Predictive Cancer Models, 26 – 27 May, 2016 - VHIO
Warning: foreach() argument must be of type array|object, false given in /usr/home/vhio.net/web/wp-content/themes/thegem-child/header.php on line 168

REGISTRATION & ABSTRACT SUBMISSION NOW OPEN: VHIO´s Special Symposium on Towards Predictive Cancer Models, 26 – 27 May, 2016

REGISTRATION & ABSTRACT SUBMISSION NOW OPEN: VHIO´s Special Symposium on Towards Predictive Cancer Models, 26 – 27 May, 2016
15 January 2016

On behalf of our two Co-Chairs, Joaquín Arribas, Director of Preclinical Research at VHIO, and Laura Soucek, Principal Investigator of VHIO´s Mouse Models of Cancer Therapies Group, we are delighted to announce that both Registration and Abstract Submission are now open for VHIO´s Special Symposium: Towards Predictive Cancer Models, 26 – 27 May 2016, Barcelona, Spain.

We invite you to browse the Scientific Program, register online today and submit your abstract by CLICKING HERE. 

For any additional information surrounding VHIO´s Special Symposium: Towards Predictive Cancer Models, 26 – 27 May 2016, please contact:

Amanda Wren • Director of Communications, the Vall d’Hebron Institute of Oncology (VHIO) • Tel. +34 695 207 886 awren@vhio.net

Related Posts

The Lancet Oncology: multicenter phase II PAMELA trial evidences HER2-E breast cancer as predictor of response to dual blockade therapy without chemotherapy

Findings reported from the open-label, single-group, and mulitcenter phase II PAMELA trial, published last week in The Lancet Oncology*, have…

27 Feb 2017
Laura Soucek Awarded for Research Inhibiting Myc Tumor Activity

Principle Investigator of VHIO´s Mouse Models of Cancer Therapy Group, Laura Soucek has been awarded this year´s Fero (Fundación de Investigación Oncológica) grant for translational cancer research for her pioneering work using mouse models to counteract tumoral activity triggered by ´the oncogene from Hell´*, Myc.

29 Jun 2011
PLoS One: Vitamin D Receptor Deficiency Enhances Wnt/ß-Catenin Signaling and Tumor Burden in Colon Cancer

CONFIRMATION THAT VITAMIN D ACTS AS A PROTECTIVE AGENT AGAINST THE ADVANCE OF COLON CANCER   A study conducted by…

16 Aug 2011
Vall d’Hebron leads international study to test a new treatment approach for metastatic HER2-positive breast cancer

 

23 Oct 2014
VI Annual FERO Grant to support 3D study of tumor DNA

This year´s annual Fero Foundation (Fundación de Investigación Oncológica) Grant for Translational Research, amounting to 70,000 EUR was presented Monday 12 May, to Sandra Peiró for a two year research project aimed at determining the three-dimensional structure of the tumor cell genome with emphasis on tumor progression and metastatis.

15 May 2014
Liquid biopsy identifies mutations in colorectal cancer that go undetected in tissue biopsy

 • The CORRECT study, published ahead of print online today in The Lancet Oncology, is one of the largest trials…

14 Jul 2015
Joan Seoane awarded ERC Proof of Concept Grant to bring ´blue sky´research towards market

The European Research Council (ERC) has awarded Joan Seoane, Director of Translational Research at the Vall d’Hebron Institute of Oncology…

24 Feb 2013
Breast cancer diagnosed during pregnancy: safely treatable without harming foetal development

Cristina Saura, Principal Investigator of VHIO´s Breast Cancer and Melanoma Group, today reported important findings during her thesis defence directed…

21 Jul 2017
WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care

The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…

17 Dec 2012
DUE TO POPULAR DEMAND ADDITIONAL GIG ON 20 DECEMBER – Jarabe de Palo´s Pau Donés: singing to support crucial research into novel therapies against colorectal cancer

IMPORTANT NOTIFICATION: As an update to this earlier news item (see below), Pau´s fundraising concert on the 22nd December is…

23 Nov 2015
Spanish periodical EL MUNDO reveals its top 25 of the most influential Spanish Citizens in Medicine for 2014

Each year, in January, the Spanish periodical EL MUNDO publishes its selection of the 500 most influential Spanish citizens for that…

10 Jan 2014
Two VHIO researchers awarded by the Spanish Association Against Cancer (AECC)

Barcelona, 18 September 2014 – Officially celebrated during yesterday´s award ceremony of the Spanish Association Against Cancer (AECC), presided by…

18 Sep 2014
Susan G. Komen awards 900.000 US$ to support VHIO research aimed at advancing insight in breast cancer

Barcelona, 23 September, 2015.– Susan G. Komen has awarded two Vall d´Hebron Institute of Oncology (VHIO) researchers with Career Catalyst…

23 Sep 2015
Election results just in: Solange Peters to take the reins as ESMO President for the 2020-2021 term

The European Society for Medical Onocology (ESMO) has just announced that the President for 2020-2021 is Solange Peters, MD, PhD,…

28 Jun 2017
The European Research Council: celebrating a 10-year success story

The first European funding entity established to promote and support frontier research of excellence – the European Research Council (ERC),…

20 Jan 2017
Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.
Privacy Policy
You have read and agreed to our privacy policy
Required